(VOVWORLD) - Pfizer on Wednesday said it will set the US price for its COVID-19 antiviral treatment Paxlovid at nearly 1,400 USD per five-day course when it moves to...
(VOVWORLD) - The US Food and Drug Administration on Thursday granted full approval to Pfizer's oral antiviral COVID-19 treatment, Paxlovid, clearing the way for the drugmaker to sell the...
(VOVWORLD) - The European Union's health regulator on Friday raised concerns over the decreasing effectiveness of COVID-19 antibody therapies to treat patients as emerging virus variants are challenging treatment...
(VOVWORLD) - Pfizer and Clear Creek Bio on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer...
(VOVWORLD) - Pfizer said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA)
(VOVWORLD) - Pfizer will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of...
(VOVWORLD) - The United States will share technologies used to make COVID-19 vaccines through the World Health Organization and is working to expand rapid testing and antiviral treatments for hard-to...
(VOVWORLD) - The World Health Organization (WHO) on Thursday endorsed the use of Pfizer Inc's oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data...
(VOVWORLD) - Thirty five generic drugmakers around the world will make cheap versions of Pfizer’s highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the UN...
(VOVWORLD) - Merck and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir was active against the fast-spreading Omicron variant
(VOVWORLD) - The US on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar...
(VOVWORLD) - Pfizer said on Thursday the US government would pay nearly 5.3 billion USD for 10 million courses of its experimental COVID-19 antiviral drug, as the country rushes...